These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2707574)

  • 21. Selective enhancement by an adenosine A1 receptor agonist of agents inducing contraction of the rat vas deferens.
    Brownhill VR; Hourani SM; Kitchen I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):499-504. PubMed ID: 8740142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus.
    Conceição IM; Jurkiewicz A; Fonseca DR; Opperman AR; Freitas TA; Lebrun I; Garcez-do-Carmo L
    Br J Pharmacol; 2005 Feb; 144(4):519-27. PubMed ID: 15678093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purinergic modulation of field stimulation responses of rat and human vas deferens smooth muscle.
    Lynch M; Huddart H
    Gen Pharmacol; 1991; 22(5):869-72. PubMed ID: 1761193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-induced facilitation of sympathetic neurotransmission to the rat vas deferens: effects of suramin.
    Lau WA; Ventura S; Jiang Q; Pennefather JN
    Eur J Pharmacol; 1995 Jan; 272(1):31-8. PubMed ID: 7536159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia caeci and bladder.
    Stone TW
    Eur J Pharmacol; 1981 Oct; 75(2-3):93-102. PubMed ID: 7318904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of alpha,beta-methylene ATP on potentiation of contractions to field stimulation of rat vas deferens by carbachol.
    Lee CM; Cheung WT
    Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):17-22. PubMed ID: 2816395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.
    Allawi HS; Wallace P; Pitcher A; Gaffen Z; Bland-Ward PA; Moore PK
    Br J Pharmacol; 1994 Sep; 113(1):282-8. PubMed ID: 7529112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contractile activity of ATP and diadenosine tetraphosphate on urinary bladder in the rat: role of A1- and P2X-purinoceptors and nitric oxide.
    Khattab MM; Al-Hrasen MN; El-Hadiyah TM
    Auton Autacoid Pharmacol; 2007 Jan; 27(1):55-62. PubMed ID: 17199876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens.
    Bültmann R; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):74-80. PubMed ID: 8139703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A contraction-mediating receptor for UTP, presumably P2Y2, in rat vas deferens.
    Bültmann R; Klebroff W; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):196-201. PubMed ID: 10494890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The purinergic component of human vas deferens contraction.
    Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G
    Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of alpha, beta-methylene ATP on the potentiation of contractions to field stimulation of the rat vas deferens by eledoisin.
    Lee CM
    Zhongguo Yao Li Xue Bao; 1987 Jul; 8(4):306-9. PubMed ID: 3445771
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors.
    Bültmann R; Szabo B; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):527-33. PubMed ID: 8391654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of purinergic receptors in the rat vas deferens.
    Taylor DA; Wiese S; Faison EP; Yarbrough GG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):40-5. PubMed ID: 6294281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evans blue blocks P2X-purinoceptors in rat vas deferens.
    Bültmann R; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):684-7. PubMed ID: 8133912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and alpha-receptors.
    Major TC; Weishaar RE; Taylor DG
    Eur J Pharmacol; 1989 Aug; 167(3):323-31. PubMed ID: 2572433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
    Göçmen C; Kumcu EK; Büyüknacar HS; Onder S; Singirik E
    Pharmacology; 2005 Oct; 75(2):69-75. PubMed ID: 16020948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens.
    Büyükafşar K; Levent A; Ark M
    Br J Pharmacol; 2003 Oct; 140(4):743-9. PubMed ID: 14504141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and ontogeny of P1-purinoceptors on rat vas deferens.
    Hourani SM; Nicholls J; Lee BS; Halfhide EJ; Kitchen I
    Br J Pharmacol; 1993 Mar; 108(3):754-8. PubMed ID: 8467361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurally evoked potentiation of tonic contractions in the guinea-pig vas deferens involves adenosine receptors.
    Tsunoo A; Kurokawa M; Takahashi K
    J Physiol; 1991 Feb; 433():163-81. PubMed ID: 1841937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.